134.80USD+0.07%Mkt Cap: 10.20B $P/E: —Today
Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophagitis, chronic obstructive pulmonary disease, and other infla…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap10.20B $
Enterprise Value9.20B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-255.84M $
Revenue/Share—
Last Price134.80 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees261
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-25.75
PEG—
EV/EBITDA-28.55
EV/Revenue—
P/S—
P/B8.47
EPS (TTM)-4.34
EPS (Forward)-5.23
52W Range
35.39100% of range134.88
52W High134.88 USD
52W Low35.39 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-28.30%
ROA-27.30%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-227.45M $
CapEx (TTM)5.15M $
FCF Margin—
FCF Yield-1.43%
Net Debt-965.09M $
Net Debt/EBITDA3.00
Balance Sheet
Debt/Equity0.01
Current Ratio26.44
Quick Ratio26.17
Book Value/Sh15.91 USD
Cash/Share12.89 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.9 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)134.85 USD
Upside (mean)+0.0%
Target Range133.00 USD – 135.11 USD
$133.00+0.0% to mean$135.11
# Analysts11
Ownership
Shares Out.62.20M
Float58.44M
Insiders2.31%
Institutions109.97%
Short Interest
Short Ratio2.7d
Short % Float7.19%
Short % Out.5.58%
Shares Short4.22M
Short (prev mo.)5.16M
Technical
SMA 50127.36 (+5.8%)
SMA 20088.50 (+52.3%)
Beta0.34
S&P 52W Chg18.16%
Avg Vol (30d)1.18M
Avg Vol (10d)1.24M
Technical Indicators
RSI (14)77.9
MACD2.5890
MACD Signal3.5649
MACD Hist.-0.9759
BB Upper134.85 USD
BB Middle134.39 USD
BB Lower133.92 USD
BB Width0.69%
ATR (14)0.6778 USD
Vol Ratio (20d)1.18x